NHS England awarded a £215m contract to Netcompany on 1 September 2026, an initial three-year term with two possible one-year extensions, covering the “digital delivery capabilities that support the development, operation and maintenance of digital products and services” for adult screening and prevention. The scope is concrete rather than exploratory: new digital communication channels through the NHS App aimed at under-screened populations, targeted selection services to identify high-risk patients, home testing rollout for cervical screening, and — the detail that matters most for AI-assisted development — direct support for “novel AI trials, allowing for AI reading of mammograms and other images.” Netcompany also keeps legacy screening systems running while replacements are built, which is the unglamorous majority of work on a contract like this.
This lands alongside a run of similar UK healthtech signals this year — record sector investment, an NHS ambient voice rollout, AI triage in the NHS App, a clinical decision support deployment in Calderdale — and confirms the pattern isn’t one flagship pilot. It’s an active buying pattern: NHS and NHS-adjacent bodies are commissioning software that has to combine genuine AI capability with the unsexy parts — legacy system integration, clinical safety cases, and delivery standards a regulator will sign off on — in the same contract, not as separate workstreams.
So what
If you’re building software that touches NHS data, clinical workflows, or a regulated health pathway, this is the bar being set by the biggest UK buyer in the space: AI features are expected, but they’re not a substitute for engineering that satisfies NHS and MHRA requirements and works with the systems that are already there. See our healthcare software development work, or get in touch to talk through what a properly scoped healthcare build looks like.